Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models
about
Differential Impacts of Alternative Splicing Networks on ApoptosisMetabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivoCell cycle proteins as promising targets in cancer therapyCelastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.Cell Cycle Regulation and Melanoma.Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines.
P2860
Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@ast
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@en
type
label
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@ast
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@en
prefLabel
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@ast
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@en
P2093
P2860
P1476
Combining an Aurora Kinase Inh ...... th in Preclinical Mouse Models
@en
P2093
Ann Richmond
Anna E Vilgelm
Jeffrey A Ecsedy
Jeffrey A Sosman
Jeffrey S Pawlikowski
Mark C Kelley
Oriana E Hawkins
P2860
P304
P356
10.1158/1078-0432.CCR-15-0293
P407
P577
2015-07-07T00:00:00Z